drugset / Trial / NCT01504620
Performance Evaluation of Blood Glucose Monitoring Systems
Phase 4
Completed
106 enrolled
IKFE Institute for Clinical Research and Development
Sanofi-Synthelabo · collab
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The goal of this single-center, comparative, open label, in-vitro diagnostic device performance evaluation was to investigate the performance of two sanofi-aventis BGMSs (BGStar® and iBGStar®) with regard to system accuracy (Polaris), precision and Hct influence (Helios).
Timeline
- Start
- 2011-01
- Primary completion
- 2011-04
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Insulin | Protein / enzyme biologic | — | Intravenous |